How Controlled Freezing becomes Reality

Single Use Support has officially received the ISO 27001:2022 certification by Quality Austria, with international recognition through IQNET. This certification independently confirms that the company has successfully implemented and maintains a comprehensive Information Security Management System across its sites in Kufstein and Hall, meeting globally recognized standards for data protection and operational security.

Advanced Fluid Management for Cell Culture Freezing, Cell Banking and Cell Therapy

Cells are important building blocks for today’s medicine and novel advanced therapies. FDA approvals for CAR-T cell therapies can be seen as proof for their ability to provide answers for many previously incurable diseases. The range of applications for cells utilized in the biopharmaceutical industry is very broad. The same is true for manufacturing processes for such therapies. The diversity of applications, be it for cell therapies, cell banking or cell culture suspension, adds to the complexity of cell-based manufacturing, which means that there is not a uniform fluid management process that applies to all cell-based suspensions. Sterile aliquotation into single-use bioprocess containers and freezing for cryopreservation of cells pose challenges for laboratories and manufacturers.

Single Use Support Announces Darren Verlenden as CEO and Strengthens Leadership Team for Further Growth and Global Expansion.

Single-use bottles continue to play a significant role in biomanufacturing, yet they often fall short in supporting closed, aseptic, and scalable fluid management. This presentation explores how automated single-use bottle filling bridges that gap. By combining process flexibility with cGMP compliance, automated systems are helping manufacturers streamline drug substance handling while staying adaptable to different bioprocessing needs. Automation is not just a technical upgrade, but a strategic enabler for modern bioprocessing. In this session, you’ll learn:
Why automation is a game changer for single-use bottle filling systems. What it takes to upgrade conventional bottle filling and scale bioprocesses for active pharmaceutical ingredients. Why flexibility is key – and how modern solutions can adapt to your biomanufacturing environments.

In the wake of the pandemic, the biotech industry is in a state of upheaval: more and more new drugs are being developed and produced. The Tyrolean company Single Use Support is actively involved in this process and continues to grow.

The Danish company Novo Holdings has acquired a 60% majority stake in the Austrian-based company Single Use Support, thereby strengthening the company's further growth on a global level.

A global biotechnology company produces different drug substances of highly valuables monoclonal antibodies (mABs). The company experienced a product loss rate between 0,5% and 5% due to the sensitivity of single-use bioprocess containers at sub-zero temperatures. Therefore, the goal was to reduce the current product loss below 0.5%.

This case study discloses how the implementation of RoSS® technologies from Single Use Support had an impact on the product loss during trials of hundreds of single-use bags. 

You will be surprised of the cost savings due to reduced product loss.

Fluid and cold chain management expert Single Use Support has opened a subsidiary in Lexington, Massachusetts. Equipped with a product showroom, the office will also serve as a base for increased US staff.

SCHOTT Pharma AG & Co. KGaA and Single Use Support GmbH are joining forces to extensively test SCHOTT Pharma’s innovative solutions for the safe and efficient handling of small volumes of pharmaceuticals at ultra-low temperatures.